IL129652A0 - Acylated cyclodextrin derivatives - Google Patents

Acylated cyclodextrin derivatives

Info

Publication number
IL129652A0
IL129652A0 IL12965297A IL12965297A IL129652A0 IL 129652 A0 IL129652 A0 IL 129652A0 IL 12965297 A IL12965297 A IL 12965297A IL 12965297 A IL12965297 A IL 12965297A IL 129652 A0 IL129652 A0 IL 129652A0
Authority
IL
Israel
Prior art keywords
cyclodextrin derivatives
acylated cyclodextrin
acylated
cyclodextrin
acyl groups
Prior art date
Application number
IL12965297A
Other languages
English (en)
Original Assignee
Poly Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poly Med filed Critical Poly Med
Publication of IL129652A0 publication Critical patent/IL129652A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/817—Entrapped within the carrier, e.g. gel, hollow fibre

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12965297A 1996-11-01 1997-10-06 Acylated cyclodextrin derivatives IL129652A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/740,778 US5916883A (en) 1996-11-01 1996-11-01 Acylated cyclodextrin derivatives
PCT/US1997/018105 WO1998020044A1 (en) 1996-11-01 1997-10-06 Acylated cyclodextrin derivatives

Publications (1)

Publication Number Publication Date
IL129652A0 true IL129652A0 (en) 2000-02-29

Family

ID=24978025

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12965297A IL129652A0 (en) 1996-11-01 1997-10-06 Acylated cyclodextrin derivatives

Country Status (13)

Country Link
US (2) US5916883A (enExample)
EP (1) EP0935613B1 (enExample)
JP (1) JP2001503802A (enExample)
AT (1) ATE219109T1 (enExample)
AU (1) AU728398B2 (enExample)
CA (1) CA2269519C (enExample)
DE (1) DE69713369T2 (enExample)
DK (1) DK0935613T3 (enExample)
ES (1) ES2176705T3 (enExample)
IL (1) IL129652A0 (enExample)
NZ (1) NZ335387A (enExample)
PT (1) PT935613E (enExample)
WO (1) WO1998020044A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
JP2000026501A (ja) * 1998-07-10 2000-01-25 Daicel Chem Ind Ltd アセチル化硝化綿及びその製造方法
DK1137666T5 (da) 1998-12-07 2009-10-05 Univ Tulane GLP-1-analoger
EP1287039A1 (en) 2000-04-28 2003-03-05 University College Dublin Amphiphilic macrocyclic derivatives and their analogues
US6566556B2 (en) * 2000-12-19 2003-05-20 Nippon Shokubai Co., Ltd. Method for production of alkanolamine and apparatus therefor
BR0102252B1 (pt) * 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
US7141540B2 (en) * 2001-11-30 2006-11-28 Genta Salus Llc Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
US7122622B2 (en) * 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
US6869939B2 (en) * 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
US6709746B2 (en) * 2002-06-05 2004-03-23 Arteva North America S.á.r.l. Reducing concentration of organic materials with substituted cyclodextrin compound in polyester packaging materials
JP2006506397A (ja) * 2002-10-31 2006-02-23 ファイザー・プロダクツ・インク 固体及び半固体高分子イオン・コンジュゲート
JP2006506396A (ja) * 2002-10-31 2006-02-23 ファイザー・プロダクツ・インク 固体医薬の液体複合体
US7166671B2 (en) * 2002-12-10 2007-01-23 Cellresin Technologies, Llc Grafted cyclodextrin
US7385004B2 (en) * 2002-12-10 2008-06-10 Cellresin Technologies, Llc Enhanced lubrication in polyolefin closure with polyolefin grafted cyclodextrin
US8129450B2 (en) 2002-12-10 2012-03-06 Cellresin Technologies, Llc Articles having a polymer grafted cyclodextrin
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP2210900A3 (en) 2003-12-16 2010-08-11 Ipsen Pharma Analogues of GLP-1
JP4908405B2 (ja) * 2004-05-24 2012-04-04 セルレジン・テクノロジーズ・エルエルシー 熱可塑性ポリマー組成物、フィルム、ファイバー、ファブリック
EP2548568B1 (en) 2005-07-08 2018-01-10 Ipsen Pharma Melanocortin receptor ligands
CN101253219B (zh) * 2005-08-31 2012-10-31 日产自动车株式会社 疏水性改性聚轮烷和交联聚轮烷
RU2470636C2 (ru) 2007-04-27 2012-12-27 Сайдекс Фамэсьютиклз, Инк. Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты)
US20090060860A1 (en) * 2007-08-31 2009-03-05 Eva Almenar Beta-cyclodextrins as nucleating agents for poly(lactic acid)
US20100256056A1 (en) 2007-09-07 2010-10-07 Zheng Xin Dong Analogues of exendin-4 and exendin-3
CN103316345B (zh) 2007-11-05 2016-05-18 益普生制药股份有限公司 黑皮质素治疗胰岛素敏感的应用
CA2729857A1 (en) 2008-07-04 2010-01-07 Traslational Cancer Drugs Pharma, S.L. Methods for the treatment and diagnosis of cancer
DK2320923T3 (en) 2008-08-07 2015-03-02 Ipsen Pharma Sas Truncated analogues of glucose-dependent insulinotropic polypeptide
KR20110043686A (ko) 2008-08-07 2011-04-27 입센 파마 에스.에이.에스 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체
MX2011001032A (es) 2008-08-07 2011-08-12 Ipsen Pharma Sas Analogos polipeptidos de insulinotropicos dependientes de glucosa (gip) modificados en n terminal.
US10463677B2 (en) 2008-11-07 2019-11-05 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CA2750074A1 (en) 2009-02-12 2010-08-19 Proyecto De Biomedicina Cima, S.L. Use of cardiotrophin-1 for the treatment of metabolic diseases
ES2769949T3 (es) 2009-05-13 2020-06-29 Cydex Pharmaceuticals Inc Composiciones farmacéuticas que comprenden prasugrel y derivados de ciclodextrina y métodos de preparación y uso de las mismas
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
ES2767880T3 (es) 2009-05-29 2020-06-18 Cydex Pharmaceuticals Inc Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de preparación y uso de las mismas
JP5571186B2 (ja) 2009-07-22 2014-08-13 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ５９位にアミノ酸置換を有するインスリン様増殖因子−１（ｉｇｆ−１）の類似体
JP6154163B2 (ja) * 2013-03-15 2017-06-28 独立行政法人国立高等専門学校機構 水不溶性シクロデキストリンポリマーおよびその製造方法
CN105561330B (zh) * 2016-01-25 2018-05-25 四川大学 一种人降钙素-葫芦脲复合制剂及其制备方法
CN112759667A (zh) * 2021-01-05 2021-05-07 淄博千汇生物科技有限公司 一种三乙酰基-β-环糊精的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) * 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US3453260A (en) * 1967-03-22 1969-07-01 Corn Products Co Cyclic anhydride esters of cyclodextrin
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4659696A (en) 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5183809A (en) * 1990-02-15 1993-02-02 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
US5247013A (en) * 1989-01-27 1993-09-21 Mitsui Toatsu Chemicals, Inc. Biocompatible polyester and production thereof
KR927003645A (ko) * 1990-05-21 1992-12-18 후지다 히로미찌 씨클로덱스트린 유도체
DE69127805T2 (de) * 1990-10-01 1998-03-12 Toppan Printing Co Ltd Cyclodextrin-polymer sowie daraus hergestellter cyclodextrin-film
US5287850A (en) * 1991-08-20 1994-02-22 Habley Medical Technology Corporation Timing and velocity controlled powered pharmaceutical inhaler
JPH06100464A (ja) * 1992-06-08 1994-04-12 Asahi Chem Ind Co Ltd カルシトニン類の経肺投与用組成物
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
DE4414128A1 (de) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Teilweise acylierte beta-Cyclodextrine
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.

Also Published As

Publication number Publication date
NZ335387A (en) 2001-05-25
DE69713369D1 (de) 2002-07-18
DK0935613T3 (da) 2002-10-07
JP2001503802A (ja) 2001-03-21
ATE219109T1 (de) 2002-06-15
US6204256B1 (en) 2001-03-20
EP0935613B1 (en) 2002-06-12
ES2176705T3 (es) 2002-12-01
AU728398B2 (en) 2001-01-11
PT935613E (pt) 2002-11-29
CA2269519A1 (en) 1998-05-14
CA2269519C (en) 2007-01-09
EP0935613A1 (en) 1999-08-18
AU4748397A (en) 1998-05-29
WO1998020044A1 (en) 1998-05-14
US5916883A (en) 1999-06-29
DE69713369T2 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
IL129652A0 (en) Acylated cyclodextrin derivatives
EP0748860A3 (en) Emulsion splitting by microorganisms
ZA976954B (en) Substituted pyrido- or pyrimido- containing 6,6- or 6,7-bicyclic derivatives
AP9400666A0 (en) Benzofuran derivatives.
HRP970454B1 (en) Substituted 6,5-hetero-bicyclic derivatives
ZA966967B (en) Acylated oligopeptide derivatives.
HU9600106D0 (en) 2,9-disubstituted purin-6-one derivatives
ZA964261B (en) Prodrugs of paclitaxel derivatives.
ZA9710542B (en) Modified 1,3-propanediol-based polyesters.
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
ZA967741B (en) Diarylalkenylamine derivatives.
ZA962753B (en) 1,3-Dihydro-2H-imidazol-2-one derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA965516B (en) Dialkyl-halogenopheyl-substituted ketoenols.
ZA979725B (en) Benzoaxozole derivative.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
EP0668289A4 (en) NEW DISACCHARIDE DERIVATIVE.
ZA967323B (en) Rockbolt nut assemblies.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
AU3840795A (en) Radiation-curable coatings based on lignin derivatives
EP0834517A4 (en) NOVEL ANTHRACYCLINE DERIVATIVES HAVING A 4-AMINO-2,4,6-TRIDESOXY-2-FLUORO-MANNOPYRANOSYL GROUP
EP0619646A3 (de) Verstärkeranordnung.
AU6532696A (en) Novel 6-substituted-5,8-dioxy-1,4-naphthoquinone derivatives
HU9301031D0 (en) An acetylene derivative hqving retinoide-like effect being substituted with heter-aromatic group and chromanyl, thio-chromanyl or tetra-hydro-quinoline one
AU4723897A (en) 1,4-benzoquinone derivatives